Ignite Creation Date:
2024-05-06 @ 10:31 AM
Last Modification Date:
2024-10-26 @ 12:31 PM
Study NCT ID:
NCT03278002
Status:
COMPLETED
Last Update Posted:
2021-10-27
First Post:
2017-08-29
Brief Title:
A Registry for Patients Taking Uptravi
Sponsor:
Actelion
Organization:
Actelion
Study Overview
Official Title:
Uptravi SelexiPag tHe usErs dRug rEgistry
Status:
COMPLETED
Status Verified Date:
2021-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SPHERE
Brief Summary:
This is a US multi-center prospective real world observational drug registry enrolling patients actively treated with Uptravi Participating patients will be followed prospectively for a maximum of 18 months from the date of enrollment into the registry
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None